© 1997 American Heart Association, Inc.
Articles |
Soluble Vascular Cell Adhesion Molecule-1 as a Biohumoral Correlate of Atherosclerosis
From the CNR Institute of Clinical Physiology (R.D.C., G.B., G.L.), I Medical Clinic (G.D., R.P.), Institute of Radiology (R.P.), and II Medical Clinic (M.M., F.C.), the University of Pisa, Pisa, Italy.
Correspondence to Raffaele De Caterina, MD, PhD, Laboratory for Thrombosis and Vascular Research, CNR Institute of Clinical Physiology, Via Savi, 8-I-56126 Pisa, Italy. E-mail rdecater{at}po.ifc.pi.cnr.it.
Abstract Vascular cell adhesion molecule-1 (VCAM-1) is a protein expressed on the surface of activated endothelial cells and expressed in early atherosclerosis. Because part of the protein is shed in the circulation and can be detected in peripheral plasma [soluble (s)VCAM-1], we hypothesized that sVCAM-1 may be a circulating marker of the presence and severity of atherosclerosis in humans. We selected 11 patients with essential hypertension plus peripheral vascular disease (PVD) and matched them for age, gender, body mass index, and smoking habits with 11 patients with uncomplicated essential hypertension (UH) and 11 healthy controls. We evaluated plasma concentrations of sVCAM-1 along with those of the soluble form of two other endothelial leukocyte adhesion molecules [sE-selectin and s-intercellular adhesion molecule-1 (sICAM-1)] and other markers of endothelial dysfunction/damage [s-thrombomodulin, plasminogen activator inhibitor type I, and von Willebrand factor (vWF)]. We also measured insulin, glucose, fibrinogen, total and HDL cholesterol, and the urinary albumin excretion (UAE), which may also be related to atherosclerosis. Results of these assays were related to the echographic assessment of the maximum intima-media thickness (IMTmax) at the carotid bifurcation, as an index of atherosclerosis in the carotids. PVD patients had a clearly elevated IMTmax [2.7 (1.1-3.1) mm, median (range)] compared with both UH patients [1.2 (0.8-2.4) mm] and controls [1 (0.6-2) mm]. sVCAM-1 was clearly higher in PVD patients [990 (273-1808) ng/mL, median (range)] versus 340 (236-975) ng/mL in UH and 386 (204-835) ng/mL in controls, and it separated clinical categories better than sICAM-1, vWF, glucose, insulin, UAE, triglycerides, or total, LDL or HDL cholesterol. sVCAM-1 was also the best biohumoral correlate of IMTmax (R=.59; P<.001) in univariate analysis. Because many of the biohumoral variables assessed were mutually intercorrelated, they were entered in a multivariate analysis to assess their contribution in explaining IMTmax variability. sVCAM-1 remained the only independent predictor of IMTmax and totally abolished the contribution of other variables to IMTmax variability. Thus, sVCAM-1 is a good biohumoral correlate of overt atherosclerosis, independent of underlying hypertension, and may be an in vivo marker of endothelial activation. Its potential value as a surrogate for global risk assessment and its behavior in intervention studies remain to be determined.
Key Words: soluble VCAM-1 • soluble ICAM-1 • intima-media thickness • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  E. Debing, E. Peeters, C. Demanet, M. De Waele, and P. Van den Brande Markers of Inflammation in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis: A Case-Control Study Vascular and Endovascular Surgery, May 1, 2008; 42(2): 122 - 127. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Gomaraschi, D. Baldassarre, M. Amato, S. Eligini, P. Conca, C. R. Sirtori, G. Franceschini, and L. Calabresi Normal Vascular Function Despite Low Levels of High-Density Lipoprotein Cholesterol in Carriers of the Apolipoprotein A-IMilano Mutant Circulation, November 6, 2007; 116(19): 2165 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study Eur. Heart J., February 1, 2007; 28(3): 354 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nozaki, H. Hikiami, H. Goto, T. Nakagawa, N. Shibahara, and Y. Shimada Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Amin, C. S. Haas, K. Zhu, P. J. Mansfield, M. J. Kim, N. P. Lackowski, and A. E. Koch Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF{kappa}B Blood, March 15, 2006; 107(6): 2252 - 2261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study Circulation, August 16, 2005; 112(7): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Parolari, L. Mussoni, M. Frigerio, M. Naliato, F. Alamanni, A. Galanti, G. Fiore, F. Veglia, E. Tremoli, P. Biglioli, et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 303 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. van Eeden, A. Yeung, K. Quinlam, and J. C. Hogg Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Cao, C. Thach, T. A. Manolio, B. M. Psaty, L. H. Kuller, P. H.M. Chaves, J. F. Polak, K. Sutton-Tyrrell, D. M. Herrington, T. R. Price, et al. C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly: The Cardiovascular Health Study Circulation, July 15, 2003; 108(2): 166 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G.A. Van Hoydonck, E. G. Schouten, and E. H.M. Temme Reproducibility of Blood Markers of Oxidative Status and Endothelial Function in Healthy Individuals Clin. Chem., June 1, 2003; 49(6): 963 - 965. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Papagianni, M. Kalovoulos, D. Kirmizis, A. Vainas, A.-M. Belechri, E. Alexopoulos, and D. Memmos Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients Nephrol. Dial. Transplant., January 1, 2003; 18(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Blann, P. M. Ridker, and G. Y.H. Lip Inflammation, Cell Adhesion Molecules, and Stroke: Tools in Pathophysiology and Epidemiology? Stroke, September 1, 2002; 33(9): 2141 - 2143. [Full Text] [PDF]
|
|
|
|
|
|
A. D. Pradhan, N. Rifai, and P. M. Ridker Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men Circulation, August 13, 2002; 106(7): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. van der Meer, M. P.M. de Maat, M. L. Bots, M. M.B. Breteler, J. Meijer, A. J. Kiliaan, A. Hofman, and J. C.M. Witteman Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of Atherosclerosis: The Rotterdam Study Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 838 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Glurich, S. Grossi, B. Albini, A. Ho, R. Shah, M. Zeid, H. Baumann, R. J. Genco, and E. De Nardin Systemic Inflammation in Cardiovascular and Periodontal Disease: Comparative Study Clin. Vaccine Immunol., March 1, 2002; 9(2): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Skoog, W. Dichtl, S. Boquist, C. Skoglund-Andersson, F. Karpe, R. Tang, M.G. Bond, U. de Faire, J. Nilsson, P. Eriksson, et al. Plasma tumour necrosis factor-{alpha} and early carotid atherosclerosis in healthy middle-aged men Eur. Heart J., March 1, 2002; 23(5): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Papayianni, E. Alexopoulos, P. Giamalis, L. Gionanlis, A.-M. Belechri, P. Koukoudis, and D. Memmos Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events Nephrol. Dial. Transplant., March 1, 2002; 17(3): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Yildirir, S. L. Tokgozoglu, I. Haznedaroglu, I. Sinici, G. Kabakci, K. Ovunc, S. Aksoyek, A. Oto, F. Ozmen, S. Kirazli, et al. Extent of Coronary Atherosclerosis and Homocysteine Affect Endothelial Markers Angiology, September 1, 2001; 52(9): 589 - 596. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Navalkar, S. Parthasarathy, N. Santanam, and B. V. Khan Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis J. Am. Coll. Cardiol., February 1, 2001; 37(2): 440 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Circulation, January 2, 2001; 103(1): 163 - 182. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kaul, S. Devaraj, and I. Jialal {{alpha}}-Tocopherol and Atherosclerosis Experimental Biology and Medicine, January 1, 2001; 226(1): 5 - 12. [Abstract] [Full Text]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Stroke, January 1, 2001; 32(1): 280 - 299. [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel, B. Lindholm, M. Heimburger, and O. Heimburger Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1624 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Jacobson, P. Thylen, and J. Lundahl Three monocyte-related determinants of atherosclerosis in haemodialysis Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1414 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. de Lemos, C. H. Hennekens, and P. M. Ridker Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk J. Am. Coll. Cardiol., August 1, 2000; 36(2): 423 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Blann and G. Y. H. Lip Editorial: Cell Adhesion Molecules in Cardiovascular Disease and Its Risk Factors--What Can Soluble Levels Tell Us? J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1745 - 1747. [Full Text]
|
|
|
|
 |
|
 W. B Strawn, R. H Dean, and C. M Ferrario Novel mechanisms linking angiotensin II and early atherogenesis Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 11 - 17. [PDF]
|
|
|
|
|
|
T. Murase, N. Kume, H. Kataoka, M. Minami, T. Sawamura, T. Masaki, and T. Kita Identification of Soluble Forms of Lectin-Like Oxidized LDL Receptor-1 Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 715 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roque, J. T. Fallon, J. J. Badimon, W. X. Zhang, M. B. Taubman, and E. D. Reis Mouse Model of Femoral Artery Denudation Injury Associated With the Rapid Accumulation of Adhesion Molecules on the Luminal Surface and Recruitment of Neutrophils Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ferri, G. Desideri, M. Valenti, C. Bellini, M. Pasin, A. Santucci, and Giancarlo De Mattia Early Upregulation of Endothelial Adhesion Molecules in Obese Hypertensive Men Hypertension, October 1, 1999; 34(4): 568 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Feng, D. M. Stern, and J. Pile-Spellman Human Endothelium: Endovascular Biopsy and Molecular Analysis Radiology, September 1, 1999; 212(3): 655 - 664. [Abstract] [Full Text]
|
|
|
|
|
|
L. E. P. Rohde, C. H. Hennekens, and P. M. Ridker Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1595 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Johansen, I. Seljeflot, A. T. Hostmark, and H. Arnesen The Effect of Supplementation With Omega-3 Fatty Acids on Soluble Markers of Endothelial Function in Patients With Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1681 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Dichtl, L. Nilsson, I. Goncalves, M. P. S. Ares, C. Banfi, F. Calara, A. Hamsten, P. Eriksson, and J. Nilsson Very Low-Density Lipoprotein Activates Nuclear Factor-{kappa}B in Endothelial Cells Circ. Res., May 14, 1999; 84(9): 1085 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ross Atherosclerosis -- An Inflammatory Disease N. Engl. J. Med., January 14, 1999; 340(2): 115 - 126. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D BLANN and G. Y H LIP Cell adhesion molecules in cardiovascular disease: what can soluble levels tell us? Heart, January 1, 1999; 81(1): 101 - 102. [Full Text]
|
|
|
|
|
|
L. E. Rohde, R. T. Lee, J. Rivero, M. Jamacochian, L. H. Arroyo, W. Briggs, N. Rifai, P. Libby, M. A. Creager, and P. M. Ridker Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ziccardi, F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, F. D'Andrea, A. M. Molinari, and D. Giugliano Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year Circulation, February 19, 2002; 105(7): 804 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]
|
|